Tata Consultancy Services and Dassault Systems partner to drive digital transformation in cardiovascular science through bio-physical simulation
Tata Consultancy Services (TCS) announced on Monday that it has partnered with Dassault Systems through its Living Heart Project, which brings together an ecosystem of cardiovascular researchers, educators, medical device developers, regulatory agencies including the US FDA, and practicing cardiologists to develop and validate realistic digital simulations of the human heart.
“The project will create groundbreaking medical solutions, including the use of heart simulation as a source of digital evidence for new cardiovascular device approvals. This includes an in-silico clinical trial that could complement the evidence drawn from clinical subjects while reducing the need for animal testing and human enrollment for clinical trials,” the company said in a regulatory filing.
TCS will employ its domain and technology knowledge, as well as its research on the Digital BioTwin of the heart, to contribute to model refinement, simulation, and technical implementation in generating and verifying highly accurate, individualized digital human heart models, according to the company.
The TCS Digital BioTwin is a biophysics-based high-fidelity computational model developed by TCS researchers to enable remote and non-invasive analysis of the functioning of a specific human organ. It aids in understanding the individual contributions of many components and evaluates their spatial interconnections. TCS has been working on developing digital bio-twins of organs such as the skin, nose, and colon. TCS will partner with Dassault Systems and others to achieve the aim of a Virtual Human Twin, with a focus on specific organs regarded as crucial to the field's progress.
“We are delighted to welcome Tata Consultancy Services to our Living Heart Project. Their deep expertise in research and technology development will bring invaluable insights to our mission and to others in the field. This collaboration demonstrates our shared commitment to leveraging the virtual world for the advancement of medical science and patient care. By joining forces, we believe we can accelerate the pace of innovation and make significant strides towards our goal of creating and delivering personalized in-silico medical solutions,” said Steve Levine, Sr. Director, Virtual Human Modeling, Dassault Systèmes and founder of The Living Heart Project.